Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.
Nat Med. 2022 May 9. doi: 10.1038/s41591-022-01800-8. Online ahead of print.
Nat Med. 2022.
PMID: 35534566